Exosome-based delivery of super-repressor IκBα ameliorates kidney ischemia-reperfusion injury

Uloženo v:
Podrobná bibliografie
Název: Exosome-based delivery of super-repressor IκBα ameliorates kidney ischemia-reperfusion injury
Autoři: Myung Yoon Kim, Tae Hyun Yoo, Dawool Han, Chulhee Choi, Jung Tak Park, Shin Wook Kang, Seonghun Kim, Jimin Park, Jong In Yook, Jae-Kwang Yoo, Nam Hee Kim, So-Hee Ahn, Seung Hyeok Han, Hyun Sil Kim, Heakyung Yoon, Cheol Hyoung Park, Bo Young Nam, Sul A Lee
Přispěvatelé: Seonghun Kim, Sul A Lee, Heakyung Yoon, Myung Yoon Kim, Jae-Kwang Yoo, So-Hee Ahn, Cheol Hyoung Park, Jimin Park, Bo Young Nam, Jung Tak Park, Seung Hyeok Han, Shin-Wook Kang, Nam Hee Kim, Hyun Sil Kim, Dawool Han, Jong In Yook, Chulhee Choi, Tae-Hyun Yoo, Kang, Shin Wook
Zdroj: Kidney International. 100:570-584
Informace o vydavateli: Elsevier BV, 2021.
Rok vydání: 2021
Témata: 0301 basic medicine, 0303 health sciences, ischemia-reperfusion injury, NF-ĸB signaling, apoptosis, Acute Kidney Injury, Exosomes, Inbred C57BL, Kidney, 3. Good health, Acute Kidney Injury* / etiology, Mice, Inbred C57BL, Mice, 03 medical and health sciences, acute kidney injury, NF-KappaB Inhibitor alpha, inflammation, Reperfusion Injury, exosome, Animals, Reperfusion Injury* / prevention & control, Acute Kidney Injury* / prevention & control
Popis: Ischemia-reperfusion injury is a major cause of acute kidney injury. Recent studies on the pathophysiology of ischemia-reperfusion-induced acute kidney injury showed that immunologic responses significantly affect kidney ischemia-reperfusion injury and repair. Nuclear factor (NF)-ĸB signaling, which controls cytokine production and cell survival, is significantly involved in ischemia-reperfusion-induced acute kidney injury, and its inhibition can ameliorate ischemic acute kidney injury. Using EXPLOR, a novel, optogenetically engineered exosome technology, we successfully delivered the exosomal super-repressor inhibitor of NF-ĸB (Exo-srIĸB) into B6 wild type mice before/after kidney ischemia-reperfusion surgery, and compared outcomes with those of a control exosome (Exo-Naïve)-injected group. Exo-srIĸB treatment resulted in lower levels of serum blood urea nitrogen, creatinine, and neutrophil gelatinase-associated lipocalin in post-ischemic mice than in the Exo-Naïve treatment group. Systemic delivery of Exo-srIĸB decreased NF-ĸB activity in post-ischemic kidneys and reduced apoptosis. Post-ischemic kidneys showed decreased gene expression of pro-inflammatory cytokines and adhesion molecules with Exo-srIĸB treatment as compared with the control. Intravital imaging confirmed the uptake of exosomes in neutrophils and macrophages. Exo-srIĸB treatment also significantly affected post-ischemic kidney immune cell populations, lowering neutrophil, monocyte/macrophage, and T cell frequencies than those in the control. Thus, modulation of NF-ĸB signaling through exosomal delivery can be used as a novel therapeutic method for ischemia-reperfusion-induced acute kidney injury.
Druh dokumentu: Article
Jazyk: English
ISSN: 0085-2538
DOI: 10.1016/j.kint.2021.04.039
Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/34051264
https://europepmc.org/article/MED/34051264
https://facultyopinions.com/prime/740200041
https://www.ncbi.nlm.nih.gov/pubmed/34051264
https://ir.ymlib.yonsei.ac.kr/handle/22282913/184772
https://pubmed.ncbi.nlm.nih.gov/34051264/
https://www.kidney-international.org/article/S0085-2538(21)00508-1/fulltext
Rights: Elsevier Non-Commercial
CC BY NC ND
Přístupové číslo: edsair.doi.dedup.....374d9e50cfbeb7b74e28fd4ec54625fa
Databáze: OpenAIRE
Popis
Abstrakt:Ischemia-reperfusion injury is a major cause of acute kidney injury. Recent studies on the pathophysiology of ischemia-reperfusion-induced acute kidney injury showed that immunologic responses significantly affect kidney ischemia-reperfusion injury and repair. Nuclear factor (NF)-ĸB signaling, which controls cytokine production and cell survival, is significantly involved in ischemia-reperfusion-induced acute kidney injury, and its inhibition can ameliorate ischemic acute kidney injury. Using EXPLOR, a novel, optogenetically engineered exosome technology, we successfully delivered the exosomal super-repressor inhibitor of NF-ĸB (Exo-srIĸB) into B6 wild type mice before/after kidney ischemia-reperfusion surgery, and compared outcomes with those of a control exosome (Exo-Naïve)-injected group. Exo-srIĸB treatment resulted in lower levels of serum blood urea nitrogen, creatinine, and neutrophil gelatinase-associated lipocalin in post-ischemic mice than in the Exo-Naïve treatment group. Systemic delivery of Exo-srIĸB decreased NF-ĸB activity in post-ischemic kidneys and reduced apoptosis. Post-ischemic kidneys showed decreased gene expression of pro-inflammatory cytokines and adhesion molecules with Exo-srIĸB treatment as compared with the control. Intravital imaging confirmed the uptake of exosomes in neutrophils and macrophages. Exo-srIĸB treatment also significantly affected post-ischemic kidney immune cell populations, lowering neutrophil, monocyte/macrophage, and T cell frequencies than those in the control. Thus, modulation of NF-ĸB signaling through exosomal delivery can be used as a novel therapeutic method for ischemia-reperfusion-induced acute kidney injury.
ISSN:00852538
DOI:10.1016/j.kint.2021.04.039